Pluri (PLUR) EBIT Margin (2011 - 2025)

Pluri (PLUR) reported EBIT Margin of 3285.86% for Q4 2025, down 60640.0% year-over-year from N/an in Q4 2024, and down 63.52% quarter-over-quarter from 2009.49% in Q3 2025.

Pluri (PLUR) EBIT Margin (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 12 years of EBIT Margin data on file, last reported at 3285.86% in Q4 2025.

  • EBIT Margin for Q4 2025 came in at 3285.86%, down 60640.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1857.88% (up 134610.0% YoY), and the FY2025 annual result was 1659.88%, up 513705.0% from the prior year.
  • EBIT Margin eased to 3285.86% in Q4 2025 per PLUR's latest filing, from 2009.49% in the prior quarter.
  • Over five years, EBIT Margin peaked at 1264.64% in Q1 2025 and troughed at 333950.0% in Q4 2022.
  • A 4-year average of 26795.99% and a median of 4964.76% in 2023 frame the typical range for EBIT Margin.
  • On a YoY basis, EBIT Margin climbed as much as 32898524 bps in 2023 and fell as far as 368442 bps in 2023.
  • A 4-year view of EBIT Margin shows it stood at 333950.0% in 2022, then surged by 99 bps to 4964.76% in 2023, then jumped by 46 bps to 2679.46% in 2024, then declined by 23 bps to 3285.86% in 2025.
  • Business Quant data shows PLUR's EBIT Margin at 3285.86% in Q4 2025, 2009.49% in Q3 2025, and 1663.57% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 38.10%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 -3,285.86%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,285.86%
Sep 30, 2025 -2,009.49%
Jun 30, 2025 -1,663.57%
Mar 31, 2025 -1,264.64%
Dec 31, 2024 -2,679.46%
Sep 30, 2024 -1,594.48%
Jun 30, 2024 -6,285.42%
Mar 31, 2024 -7,794.37%
Dec 31, 2023 -4,964.76%
Sep 30, 2023 -9,957.41%
Jun 30, 2023 -5,895.50%
Mar 31, 2023 -8,160.92%
Dec 31, 2022 -333,950.00%
Sep 30, 2022 -7,957.47%
Mar 31, 2022 -4,476.50%
Dec 31, 2019 -27,686.96%
Dec 31, 2018 -16,662.00%
Sep 30, 2018 -224,250.00%
Dec 31, 2017 -16,934.00%
Dec 31, 2015 -153.63%